FDA Inspection
American Reproductive CentersAmerican Reproductive Centers – FDA Inspection, Dec 6, 2023
Record Details
This FDA Inspection record concerns American Reproductive Centers, with an inspection on December 6, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f96b37d1-1db0-47de-b693-9a2618a1386c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1224796
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.50(a)Responsible person to determine, document
- 21 CFR 1271.80(b)Specimen collections not timely
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Reproductive Centers
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 17, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 29, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for American Reproductive Centers
- FDA Inspection 1067661 - 2018-09-12
- FDA Inspection 887867 - 2014-07-17
- FDA Inspection 799852 - 2012-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.